Tracking changes in image-defined risk factors during neoadjuvant chemotherapy and their predictive value for surgical outcomes based on the International Neuroblastoma Surgical Report Form

被引:0
作者
Liu, Tao [1 ]
Sheng, Qingfeng [1 ]
Xu, Weijue [1 ]
Lu, Li [1 ]
Zhu, Linlin [1 ]
Xiong, Jing [1 ]
Jiang, Shayi [2 ]
Yang, Xiujun [3 ]
Liu, Jiangbin [1 ]
Lv, Zhibao [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Sch Med, Dept Gen Surg, Shanghai 200040, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Hematol & Oncol, Sch Med, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Sch Med, Dept Radiol, Shanghai, Peoples R China
关键词
chemotherapy; IDRFs; neuroblastoma; surgery; LOCALIZED NEUROBLASTOMA; RECOMMENDATIONS; CHILDREN; SURGERY;
D O I
10.1002/pbc.31161
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe capacity of presurgical image-defined risk factors (IDRFs) to predict secondary surgical outcomes in patients with neuroblastoma is controversial.MethodsThe International Neuroblastoma Surgical Report Form (INSRF) was employed to retrospectively collect the clinical data of 53 patients diagnosed with neuroblastoma at our hospital from April 2014 to April 2020. IDRFs were identified at the time of diagnosis and reassessed during the course of neoadjuvant chemotherapy. Various statistical tests were used to evaluate the correlation between IDRFs and secondary surgical outcomes.ResultsA total of 195 IDRFs were identified. Notably, by two courses of neoadjuvant chemotherapy, the number of "two body compartments," "intraspinal tumor extension," and "trachea-compressing" IDRFs decreased significantly (p = .001). The primary tumor volumes and the number of IDRFs decreased significantly by four courses of neoadjuvant chemotherapy, especially in "intraspinal tumor extension" IDRFs (p = .034). The median number of IDRF per patient was four (interquartile range [IQR]: 1-5) at diagnosis, which diminished to one (IQR: 1-3) subsequent to neoadjuvant chemotherapy. The presence of preoperative IDRFs was not associated with surgical complications (p = .286) or the extent of surgery (p = .188). However, the number of preoperative IDRFs linked to the extent of surgery (p = .002), not to operative complications (p = .669). Specifically, presurgery "renal vessel contact" IDRFs were predictive of surgical complications, while presurgery "infiltration of vital structures" IDRFs were associated with the extent of surgery.ConclusionThe number of IDRFs decreased significantly by four courses of neoadjuvant chemotherapy. The number and type of presurgery IDRFs may predict secondary surgical outcomes, surpassing the mere consideration of their presence or absence.
引用
收藏
页数:11
相关论文
共 28 条
  • [1] Role of surgery in localized initially unresectable neuroblastoma
    Ahmed, Gehad
    Fawzy, Mohamed
    Elmenawi, Salma
    Elzomor, Hossam
    Yosif, Yasser
    Elkinaai, Naglaa
    Refaat, Amal
    Hegazy, Mohamed
    El Shafiey, Maged
    [J]. JOURNAL OF PEDIATRIC UROLOGY, 2018, 14 (03) : 231 - 236
  • [2] Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes
    Avanzini, Stefano
    Pio, Luca
    Erminio, Giovanni
    Granata, Claudio
    Holmes, Keith
    Gambart, Marion
    Buffa, Piero
    Castel, Victoria
    Couanet, Dominique Valteau
    Garaventa, Alberto
    Pistorio, Angela
    Cecchetto, Giovanni
    Martucciello, Giuseppe
    Mattioli, Girolamo
    Sarnacki, Sabine
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [3] Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015
    Berthold, Frank
    Spix, Claudia
    Kaatsch, Peter
    Lampert, Fritz
    [J]. PEDIATRIC DRUGS, 2017, 19 (06) : 577 - 593
  • [4] Guidelines for Imaging and Staging of Neuroblastic Tumors: Consensus Report from the International Neuroblastoma Risk Group Project
    Brisse, Herve J.
    McCarville, M. Beth
    Granata, Claudio
    Krug, K. Barbara
    Wootton-Gorges, Sandra L.
    Kanegawa, Kimio
    Giammarile, Francesco
    Schmidt, Matthias
    Shulkin, Barry L.
    Matthay, Katherine K.
    Lewington, Valerie J.
    Sarnacki, Sabine
    Hero, Barbara
    Kaneko, Michio
    London, Wendy B.
    Pearson, Andrew D. J.
    Cohn, Susan L.
    Monclair, Tom
    [J]. RADIOLOGY, 2011, 261 (01) : 243 - 257
  • [5] Surgical risk factors in primary surgery for localized neuroblastoma:: The LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group
    Cecchetto, G
    Mosseri, V
    De Bernardi, B
    Helardot, P
    Monclair, T
    Costa, E
    Horcher, E
    Neuenschwander, S
    Tomà, P
    Rizzo, A
    Michon, J
    Holmes, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8483 - 8489
  • [6] Effects of preoperative chemotherapy on neuroblastoma with MYCN amplification: a surgeon's perspective
    Chui, Chanhon
    [J]. WORLD JOURNAL OF PEDIATRIC SURGERY, 2020, 3 (02)
  • [7] The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
    Cohn, Susan L.
    Pearson, Andrew D. J.
    London, Wendy B.
    Monclair, Tom
    Ambros, Peter F.
    Brodeur, Garrett M.
    Faldum, Andreas
    Hero, Barbara
    Iehara, Tomoko
    Machin, David
    Mosseri, Veronique
    Simon, Thorsten
    Garaventa, Alberto
    Castel, Victoria
    Matthay, Katherine K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (02) : 289 - 297
  • [8] Radiographic assessment of resectability of locoregional disease in children with high-risk neuroblastoma during neoadjuvant chemotherapy
    Davidoff, AM
    Corey, BL
    Hoffer, FA
    Santana, VM
    Furman, WL
    Shochat, SJ
    [J]. PEDIATRIC BLOOD & CANCER, 2005, 44 (02) : 158 - 162
  • [9] Outcomes Following GD2-Directed Postconsolidation Therapy for Neuroblastoma After Cessation of Random Assignment on ANBL0032: A Report From the Children's Oncology Group
    Desai, Ami, V
    Gilman, Andrew L.
    Ozkaynak, Mehmet Fevzi
    Naranjo, Arlene
    London, Wendy B.
    Tenney, Sheena C.
    Diccianni, Mitchell
    Hank, Jacquelyn A.
    Parisi, Marguerite T.
    Shulkin, Barry L.
    Smith, Malcolm
    Moscow, Jeffrey A.
    Shimada, Hiroyuki
    Matthay, Katherine K.
    Cohn, Susan L.
    Maris, John M.
    Bagatell, Rochelle
    Sondel, Paul M.
    Park, Julie R.
    Yu, Alice L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (35) : 4107 - +
  • [10] Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy
    Du, Lei
    Liu, Ling
    Zhang, Chi
    Cai, Wei
    Wu, Yeming
    Wang, Jun
    Lv, Fan
    [J]. JOURNAL OF PEDIATRIC SURGERY, 2014, 49 (04) : 528 - 533